Table 4.

Distribution of HCC risk based on the THCC Risk Index in the Texas Hepatocellular Carcinoma Consortium (THCCC) and the Houston Veterans Administration Cirrhosis Surveillance Cohorts (HVASC) [Derivation Cohort] and the Veterans Health Administration Cirrhosis Cohort [Validation Cohort].

	Cumulative HCC incidence (95% confidence interval)
Decile	Year 1	Year 2	Year 3
1	0 (0, 0)	0.4 (0, 1.2)	0.4 (0, 1.2)
2	0.4 (0, 1.2)	0.8 (0, 2.0)	0.8 (0, 2.0)
3	1.2 (0, 2.6)	2.1 (0.3, 3.9)	3.3 (0.8, 5.8)
4	0.4 (0, 1.2)	0.8 (0, 2.0)	2.7 (0.3, 5.1)
5	1.7 (0.1, 3.3)	2.2 (0.2, 4.2)	3.9 (1.2, 6.6)
6	0.8 (0, 2.0)	1.3 (0, 2.7)	4.3 (1.4, 7.2)
7	0.9 (0, 2.1)	2.7 (0.5, 4.9)	2.7 (0.5, 4.9)
8	3.3 (0.9, 5.7)	4.2 (1.7, 6.7)	6.7 (3.2, 10.2)
9	3.4 (1.0, 5.8)	10.0 (6.1, 13.9)	11.9 (7.4, 16.4)
10	8.9 (5.2, 12.6)	17.1 (12, 22.2)	24.0 (17.7, 30.3)